"If you are suffering from psoriasis, eczema or other skin diseases, we are seeking volunteers for participation in one of our clinical trials. At Menter Dermatology Research Institute we are constantly adding new clinical trials. Check our website for a list of clinical trial and sign up to receive an email regarding future clinical trials."

During the past decade, Menter Dermatology Research Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 22 clinical trials were completed, i.e. on average, 129.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Menter Dermatology Research Institute" #1 sponsor was "Pfizer" with 6 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "University of Pennsylvania" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Menter Dermatology Research Institute" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Dermatology Research Institute" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "Janssen Services, LLC" with 1 trials as a collaborator and "National Psoriasis Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Menter Dermatology Research Institute" are "Psoriasis" (14 trials), "Plaque Psoriasis" (6 trials), "Atopic Dermatitis" (3 trials), "Psoriasis Vulgaris" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Menter Dermatology Research Institute" in a lesser frequency.

Most popular intervention types in "Menter Dermatology Research Institute" are "Drug" (28 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "BMS-986165" (2 trials), "CP-690,550" (2 trials), "Guselkumab" (2 trials) and "Ixekizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Menter Dermatology Research Institute" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Menter Dermatology Research Institute". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Menter Dermatology Research Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Menter Dermatology Research Institute, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".